MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 by Intellectual Property Watch 1 Comment The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines.
Paper: National Laws, UPOV, Should Be Revised To Ensure Farmers Rights 05/05/2017 by Intellectual Property Watch 1 Comment The right of farmers to use, exchange and sell farm-saved seeds should be ensured through national laws and a revision of the International Union for the Protection of New Varieties of Plants (UPOV), so the objectives of another United Nations international treaty on plant genetic resources can be fulfilled, a recent research paper states.
WIPO Promotes IP Flexibilities Database 05/05/2017 by Intellectual Property Watch Leave a Comment The UN World Intellectual Property Organization this week promoted a database it has developed containing a collection of flexibilities to IP laws in countries around the world.
WHO Project To Prequalify Biosimilar Cancer Medicines Aims At Increased Affordability 04/05/2017 by Intellectual Property Watch 1 Comment The World Health Organization announced today that it will launch a pilot project in 2017 for prequalifying cancer biosimilar medicines, with the intent of lowering prices on some of the most expensive cancer treatments.
New Open Source Project Enlists Students To Find Cures For Neglected Diseases 03/05/2017 by Intellectual Property Watch 1 Comment The Drugs for Neglected Diseases initiative (DNDi) has launched a collaborative project with five universities in India, United Kingdom, and the United States to help with the research on a debilitating neglected disease.
New R&D Funding Model For TB, Antimicrobial Resistance 01/05/2017 by Intellectual Property Watch 3 Comments The World Health Organization Bulletin this month has an article about the need for new models of research and development for tuberculosis and antimicrobial resistance. The article describes a new funding framework called the 3P Project.
New Open Source Licence For Seeds 28/04/2017 by Intellectual Property Watch 7 Comments The Germany-based OpenSourceSeeds initiative this month started to offer open source-licensed seeds in an effort to strengthen a form of “copyleft” for new plant varieties. The goal, according to the organisation established by academics, activists and breeders and establish a non-private seed sector as a second pillar alongside private plant breeding.
US Government Intends To Grant Exclusive Licence On Zika Patent Over Objection Of Civil Society 26/04/2017 by Intellectual Property Watch 1 Comment The United States Department of Defense has announced that it intends to grant Sanofi Pasteur, a French pharmaceutical corporation, exclusive rights to develop a vaccine for the Zika virus. The decision follows outcry from the public and civil society groups over concerns of affordability and accessibility in taking such a step.
The Creative Power Of Musical Borrowing And Efforts To Control It 23/04/2017 by Intellectual Property Watch 1 Comment Duke Today writes: To borrow from Cole Porter, Tchaikovsky did it. Beethoven did it. Even Robert Johnson and Ray Charles did it. Creative masters all, they each appropriated music from others in their works and were borrowed from in turn.
Licence For A New Hepatitis Treatment, With An Eye To Affordability 21/04/2017 by Intellectual Property Watch 2 Comments The Medicines Patent Pool has received a licence to develop ravidasvir, a new treatment for hepatitis C.